Form 4: AdaptHealth Director Dale Wolf Reports Stock Acquisition and Trust Holdings
Insider Transaction Report
AdaptHealth Corp. Director Dale B. Wolf reported the acquisition of 21,346 shares of common stock at a price of $0, increasing his direct beneficial ownership to 96,235 shares, in addition to 14,000 shares held indirectly through a trust.
Summary
- Dale B. Wolf, a Director of AdaptHealth Corp., acquired 21,346 shares of common stock.
- The acquisition occurred on June 26, 2025, at a price of $0 per share.
- Following this transaction, Dale B. Wolf directly beneficially owns 96,235 shares of AdaptHealth Corp. common stock.
- An additional 14,000 shares are indirectly beneficially owned through the Dale B. Wolf Generation Skipping Trust, for which Mr. Wolf is the investment manager.
- A Power of Attorney was granted by Dale Wolf on April 16, 2024, to Jonathan B. Bush and Shannone Raybon to facilitate SEC filings on his behalf.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director, even if compensation-related, increases insider alignment. The filing is a routine compliance document.
Positives
- The acquisition of 21,346 shares by a director, even if compensation-related, increases insider ownership, which can be viewed as aligning management interests with shareholders.
Negatives
- The acquisition price of $0 suggests these shares were likely granted as compensation (e.g., restricted stock units vesting) rather than an open market purchase, which might not signal the same level of direct confidence as a cash buy.
Future Outlook
NA
Industry Context
This Form 4 filing is a routine disclosure of insider stock transactions, common across all publicly traded companies. It reflects a change in a director's beneficial ownership, which is a standard event in the healthcare services industry as executives receive equity compensation or adjust their holdings.
Comparison to Industry Standards
- NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization of Agent | Dale Wolf granted a Power of Attorney to Jonathan B. Bush and Shannone Raybon to prepare and submit SEC filings on his behalf, including Forms 3, 4, 5, Schedules 13D, 13G, and Forms 144. | April 16, 2024 | This streamlines the compliance process for the director's reporting obligations under Section 13 and 16 of the Exchange Act, ensuring timely and accurate filings. It clarifies that the director retains ultimate responsibility for compliance. |
Related Party Transactions
- Dale B. Wolf indirectly beneficially owns 14,000 shares through the Dale B. Wolf Generation Skipping Trust, for which he is the investment manager. This is a common arrangement for personal holdings.
Stakeholder Impact
- Shareholders: Increased insider ownership may be seen as a positive signal of management's alignment with shareholder interests, though the $0 acquisition price suggests compensation rather than a direct market purchase.
Key Dates
| Date | Description |
|---|---|
| April 16, 2024 | Date Dale Wolf executed the Power of Attorney. |
| June 26, 2025 | Date of the reported transaction where Dale B. Wolf acquired common stock. |
| June 30, 2025 | Date the Form 4 was signed by the attorney-in-fact for Dale Wolf. |
Recommendation
holdKeywords
AdaptHealth Corp., AHCO, Dale B. Wolf, Director, Insider Trading, Form 4, Stock Acquisition, Beneficial Ownership, SEC Filing, Corporate Governance, Trust Holdings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.